SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-140440
Filing Date
2020-05-12
Accepted
2020-05-12 16:17:03
Documents
3
Period of Report
2020-05-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917379d8k.htm 8-K 21258
2 EX-3.1 d917379dex31.htm EX-3.1 28347
3 EX-3.2 d917379dex32.htm EX-3.2 178226
  Complete submission text file 0001193125-20-140440.txt   229027
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39279 | Film No.: 20869329
SIC: 2836 Biological Products, (No Diagnostic Substances)